NPI: 1134165970 · CINCINNATI, OH 45237 · Clinical Medical Laboratory · NPI assigned 06/21/2006
Authorized official TIMMERMAN, LEAH controls 20+ related entities in our dataset. Read more
| Authorized Official | TIMMERMAN, LEAH (SR. VP) |
| Parent Organization | QUEST DIAGNOSTICS INCORPORATED |
| NPI Enumeration Date | 06/21/2006 |
Other providers sharing the same authorized official: TIMMERMAN, LEAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,252,574 | $27.03M |
| 2019 | 2,128,319 | $29.38M |
| 2020 | 1,633,730 | $25.17M |
| 2021 | 1,655,944 | $28.81M |
| 2022 | 1,546,586 | $23.20M |
| 2023 | 1,528,294 | $19.44M |
| 2024 | 1,146,955 | $14.14M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 597,006 | 363,413 | $19.91M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 326,499 | 220,168 | $17.99M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 114,629 | 105,627 | $7.59M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 237,850 | 221,572 | $4.70M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 235,705 | 219,388 | $4.69M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 67,434 | 41,724 | $4.67M |
| 80053 | Comprehensive metabolic panel | 664,133 | 625,822 | $4.37M |
| 80061 | Lipid panel | 486,486 | 462,243 | $4.03M |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 88,491 | 83,171 | $3.86M |
| 84443 | Thyroid stimulating hormone (TSH) | 359,985 | 342,653 | $3.86M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 204,600 | 193,570 | $3.48M |
| 80050 | General health panel | 130,896 | 122,433 | $3.33M |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 196,239 | 186,084 | $2.97M |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 9,866 | 8,618 | $2.75M |
| 87799 | 115,438 | 43,121 | $2.61M | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 147,935 | 138,578 | $2.51M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 488,963 | 459,922 | $2.45M |
| 87522 | Neg quan hep c or qual rna | 83,963 | 79,400 | $2.08M |
| 80362 | 171,690 | 80,218 | $2.02M | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 9,044 | 8,454 | $1.93M |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 20,732 | 14,631 | $1.91M |
| 80074 | 72,542 | 68,369 | $1.91M | |
| 87902 | 12,377 | 11,718 | $1.90M | |
| 80355 | 212,711 | 98,696 | $1.83M | |
| 86480 | 49,290 | 47,121 | $1.83M | |
| 80348 | 184,302 | 89,777 | $1.67M | |
| 82607 | 166,669 | 158,615 | $1.60M | |
| 83036 | Hemoglobin; glycosylated (A1C) | 262,115 | 249,699 | $1.49M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 12,392 | 11,173 | $1.36M |
| 86803 | 149,971 | 142,824 | $1.32M | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 12,193 | 11,546 | $1.30M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 58,743 | 55,748 | $1.24M |
| 80373 | 140,619 | 67,244 | $1.18M | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 225,264 | 209,803 | $1.18M |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 70,433 | 67,256 | $1.16M |
| 87512 | 43,374 | 40,793 | $1.12M | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 53,660 | 49,776 | $1.12M |
| 80354 | 127,515 | 70,714 | $1.11M | |
| 80346 | 80,003 | 46,692 | $1.09M | |
| 87088 | 181,372 | 169,338 | $987K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 4,633 | 4,220 | $946K |
| 80361 | 79,909 | 47,956 | $937K | |
| 81513 | 33,744 | 31,564 | $900K | |
| 82746 | 96,398 | 91,874 | $886K | |
| 80368 | 102,261 | 48,425 | $857K | |
| 83013 | 18,981 | 17,876 | $837K | |
| 80349 | 98,636 | 52,764 | $773K | |
| 80081 | 17,584 | 16,205 | $766K | |
| 36415 | Collection of venous blood by venipuncture | 521,205 | 479,706 | $754K |
| 80360 | 91,570 | 39,814 | $749K | |
| 86003 | 15,302 | 8,708 | $676K | |
| 82728 | 71,469 | 67,882 | $621K | |
| 80366 | 64,287 | 32,073 | $594K | |
| 80369 | 67,210 | 32,476 | $580K | |
| 80324 | 69,833 | 43,895 | $565K | |
| 87340 | 90,651 | 86,666 | $560K | |
| 84439 | 92,367 | 86,890 | $543K | |
| 87070 | 89,522 | 84,032 | $516K | |
| 84403 | 31,507 | 29,709 | $515K | |
| 80321 | 48,445 | 28,318 | $495K | |
| 80353 | 62,602 | 37,225 | $490K | |
| 80356 | 58,815 | 35,930 | $463K | |
| 80365 | 63,885 | 38,570 | $462K | |
| 87186 | 75,709 | 70,006 | $438K | |
| 85027 | 106,538 | 100,113 | $435K | |
| 86696 | 29,512 | 27,535 | $410K | |
| 80358 | 52,037 | 31,161 | $410K | |
| 84153 | 35,070 | 33,464 | $401K | |
| 86235 | 9,571 | 6,319 | $398K | |
| 80372 | 43,557 | 19,181 | $395K | |
| 87077 | 70,505 | 66,131 | $392K | |
| 86706 | 54,065 | 51,781 | $374K | |
| 86704 | 47,197 | 45,027 | $366K | |
| 83550 | 65,949 | 62,829 | $360K | |
| 83655 | 42,429 | 40,788 | $356K | |
| 83970 | 11,758 | 10,967 | $313K | |
| 83540 | 74,016 | 70,454 | $311K | |
| 86592 | 115,396 | 110,206 | $307K | |
| 82652 | 14,545 | 13,813 | $307K | |
| 80345 | 38,680 | 21,938 | $294K | |
| 86708 | 35,263 | 33,779 | $283K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 54,502 | 48,085 | $282K |
| 82570 | 118,017 | 95,101 | $280K | |
| 81596 | 7,186 | 6,746 | $262K | |
| 80359 | 35,011 | 19,078 | $260K | |
| 84702 | 28,178 | 23,501 | $258K | |
| 86695 | 28,190 | 26,316 | $256K | |
| 86038 | 31,724 | 30,048 | $255K | |
| 82043 | 67,235 | 63,747 | $250K | |
| 83001 | 19,739 | 18,675 | $240K | |
| 83735 | 57,562 | 53,973 | $238K | |
| 87081 | 53,820 | 49,967 | $235K | |
| 82670 | 13,292 | 12,580 | $235K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 16,361 | 15,116 | $234K |
| 86787 | 27,289 | 24,951 | $234K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 10,096 | 8,277 | $234K |
| 84436 | 54,704 | 52,465 | $229K | |
| 80371 | 23,452 | 11,251 | $224K | |
| 84402 | 13,604 | 12,905 | $222K | |
| 86769 | 5,676 | 5,409 | $218K | |
| 84481 | 19,919 | 18,736 | $218K | |
| 87480 | 15,539 | 14,852 | $201K | |
| 87510 | 15,525 | 14,839 | $200K | |
| 80335 | 21,525 | 11,516 | $197K | |
| 87660 | 15,577 | 14,889 | $196K | |
| 84479 | 46,986 | 45,190 | $189K | |
| 84146 | 14,904 | 14,081 | $186K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5,011 | 4,784 | $183K |
| 86780 | 23,519 | 21,782 | $182K | |
| 88142 | 12,953 | 12,251 | $170K | |
| 80076 | 33,670 | 32,313 | $168K | |
| 83002 | 13,514 | 12,796 | $164K | |
| 83880 | 7,276 | 6,841 | $158K | |
| 81001 | 72,096 | 66,948 | $152K | |
| 80323 | 10,962 | 5,737 | $150K | |
| 86762 | 19,596 | 18,623 | $149K | |
| 82248 | 43,240 | 40,589 | $135K | |
| 87563 | 6,314 | 6,046 | $134K | |
| 87147 | 35,850 | 33,973 | $131K | |
| 82105 | 12,003 | 11,461 | $130K | |
| 86317 | 13,117 | 12,354 | $122K | |
| 81025 | 27,095 | 10,786 | $118K | |
| 86376 | 11,697 | 11,087 | $115K | |
| 88141 | 10,510 | 10,002 | $114K | |
| 84144 | 8,442 | 7,936 | $112K | |
| 83992 | 12,215 | 6,919 | $108K | |
| 86200 | 12,185 | 11,512 | $107K | |
| 84681 | 8,211 | 7,792 | $104K | |
| 80374 | 12,595 | 9,390 | $104K | |
| 83698 | 3,831 | 3,721 | $102K | |
| 83525 | 13,585 | 12,975 | $101K | |
| 83704 | 4,775 | 4,652 | $97K | |
| 86705 | 13,270 | 12,965 | $97K | |
| 86431 | 24,311 | 23,060 | $93K | |
| 86665 | 4,612 | 3,624 | $93K | |
| 86140 | 29,346 | 26,330 | $93K | |
| 82627 | 6,483 | 6,188 | $93K | |
| 83520 | 10,484 | 8,225 | $88K | |
| 83690 | 19,175 | 18,030 | $88K | |
| 84550 | 29,128 | 27,462 | $87K | |
| 87209 | 7,387 | 6,002 | $86K | |
| 86800 | 7,649 | 7,224 | $80K | |
| 84480 | 10,248 | 9,721 | $80K | |
| 87517 | 2,861 | 2,735 | $80K | |
| 83516 | 9,668 | 7,101 | $77K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 3,202 | 3,010 | $76K |
| 84270 | 5,405 | 5,153 | $74K | |
| 87631 | 814 | 794 | $73K | |
| 82785 | 6,178 | 5,887 | $72K | |
| 82784 | 8,593 | 7,982 | $70K | |
| 82150 | 16,245 | 15,291 | $69K | |
| 86765 | 8,343 | 7,915 | $68K | |
| 86735 | 8,195 | 7,786 | $67K | |
| 84100 | 23,006 | 21,200 | $67K | |
| 87536 | 1,299 | 1,235 | $67K | |
| 82951 | 8,016 | 7,538 | $66K | |
| 85610 | 25,619 | 21,969 | $65K | |
| 84703 | 12,706 | 12,050 | $64K | |
| 86850 | 15,787 | 15,009 | $64K | |
| 85652 | 35,365 | 32,247 | $63K | |
| 86709 | 8,442 | 8,130 | $63K | |
| 87650 | 5,134 | 5,025 | $62K | |
| 86160 | 4,263 | 3,640 | $62K | |
| 81443 | 314 | 286 | $61K | |
| 87075 | 9,586 | 9,016 | $59K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2,527 | 1,305 | $56K |
| 86141 | 6,299 | 6,029 | $56K | |
| 84425 | 4,164 | 3,943 | $56K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 4,327 | 3,806 | $56K |
| 82550 | 12,884 | 11,711 | $54K | |
| 86225 | 5,785 | 5,482 | $53K | |
| 82950 | 17,723 | 16,669 | $53K | |
| 87481 | 4,721 | 1,722 | $51K | |
| 86364 | 2,786 | 2,683 | $49K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 5,381 | 5,096 | $47K |
| 83021 | 3,737 | 3,387 | $45K | |
| 80363 | 2,764 | 1,416 | $45K | |
| 82672 | 3,124 | 3,016 | $45K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 3,088 | 3,042 | $45K |
| 83695 | 5,065 | 4,924 | $43K | |
| 83721 | 9,731 | 9,352 | $43K | |
| 80164 | 4,906 | 4,519 | $43K | |
| 87177 | 7,429 | 6,037 | $43K | |
| 86039 | 5,755 | 5,457 | $42K | |
| 82140 | 4,372 | 4,059 | $42K | |
| 87255 | 1,848 | 1,787 | $42K | |
| 83014 | 7,601 | 7,187 | $41K | |
| 87625 | 3,039 | 2,895 | $41K | |
| 80338 | 3,058 | 1,352 | $41K | |
| 81003 | 53,709 | 33,565 | $41K | |
| 82542 | 3,265 | 3,029 | $39K | |
| 86664 | 3,630 | 3,433 | $39K | |
| 82172 | 3,406 | 3,322 | $38K | |
| 82977 | 7,870 | 7,479 | $37K | |
| 86255 | 6,158 | 2,205 | $37K | |
| 82677 | 1,844 | 1,732 | $35K | |
| 82533 | 3,183 | 2,935 | $34K | |
| 80325 | 5,404 | 2,068 | $33K | |
| 87205 | 11,613 | 10,912 | $32K | |
| 84154 | 2,787 | 2,669 | $31K | |
| 80332 | 3,539 | 1,368 | $31K | |
| 86147 | 1,830 | 684 | $31K | |
| 84156 | 12,803 | 11,609 | $30K | |
| 81329 | 844 | 759 | $29K | |
| 86757 | 1,342 | 1,063 | $28K | |
| 83020 | 3,987 | 3,731 | $28K | |
| 86618 | 2,424 | 2,349 | $28K | |
| 82465 | 8,560 | 8,180 | $27K | |
| 83921 | 2,280 | 2,205 | $27K | |
| 83498 | 1,519 | 1,447 | $26K | |
| 84207 | 1,470 | 1,388 | $26K | |
| 82565 | 7,987 | 7,403 | $26K | |
| 87427 | 3,227 | 2,981 | $25K | |
| 85018 | 16,366 | 15,556 | $25K | |
| 85730 | 7,531 | 7,036 | $24K | |
| 83615 | 5,615 | 5,179 | $24K | |
| 87045 | 3,706 | 3,450 | $24K | |
| 82274 | 2,201 | 2,092 | $23K | |
| 85060 | 2,715 | 2,624 | $22K | |
| 86336 | 1,839 | 1,728 | $22K | |
| 87338 | 2,300 | 2,235 | $22K | |
| 86901 | 13,139 | 12,505 | $20K | |
| 86334 | 1,423 | 1,341 | $20K | |
| 84466 | 2,393 | 2,301 | $19K | |
| 86900 | 13,052 | 12,422 | $19K | |
| 83519 | 2,117 | 859 | $19K | |
| 86341 | 1,797 | 988 | $19K | |
| 87449 | 2,779 | 2,302 | $19K | |
| 80367 | 2,929 | 2,021 | $18K | |
| 86617 | 1,334 | 876 | $18K | |
| 84460 | 5,469 | 5,224 | $18K | |
| 36416 | 11,185 | 10,841 | $18K | |
| 80178 | 4,162 | 3,779 | $18K | |
| 87329 | 2,299 | 2,219 | $17K | |
| 84478 | 4,331 | 3,699 | $17K | |
| 86146 | 1,030 | 379 | $17K | |
| 86381 | 755 | 724 | $16K | |
| 85045 | 5,855 | 5,501 | $16K | |
| 86008 | 1,859 | 1,761 | $15K | |
| 82310 | 4,785 | 4,528 | $15K | |
| 84450 | 4,704 | 4,495 | $15K | |
| 80177 | 1,678 | 1,629 | $15K | |
| 82024 | 651 | 623 | $15K | |
| 83090 | 1,449 | 1,404 | $15K | |
| 87076 | 2,188 | 1,999 | $15K | |
| 84165 | 2,047 | 1,932 | $15K | |
| 85014 | 9,069 | 8,580 | $14K | |
| 87046 | 2,012 | 1,799 | $14K | |
| 86648 | 1,618 | 1,431 | $14K | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 1,868 | 1,734 | $13K |
| 82330 | 1,625 | 1,563 | $13K | |
| 86774 | 1,636 | 1,447 | $13K | |
| 80069 | 2,538 | 2,317 | $12K | |
| 84520 | 5,156 | 4,817 | $12K | |
| 86666 | 1,012 | 691 | $12K | |
| 82947 | 4,968 | 4,720 | $12K | |
| 82397 | 1,095 | 1,050 | $12K | |
| 85041 | 6,152 | 5,770 | $12K | |
| 81512 | 527 | 485 | $12K | |
| 85007 | 5,272 | 4,877 | $12K | |
| 80320 | 1,652 | 422 | $12K | |
| 82247 | 3,700 | 3,154 | $12K | |
| 83718 | 2,160 | 2,095 | $11K | |
| 86593 | 4,094 | 3,810 | $11K | |
| 82103 | 1,312 | 1,253 | $11K | |
| 87324 | 1,397 | 1,343 | $11K | |
| 85379 | 1,651 | 1,577 | $11K | |
| 81243 | 1,200 | 1,080 | $11K | |
| 84445 | 341 | 334 | $11K | |
| 86015 | 774 | 743 | $10K | |
| 87529 | 361 | 235 | $10K | |
| 83883 | 946 | 765 | $10K | |
| 84305 | 697 | 673 | $10K | |
| 82040 | 3,130 | 2,982 | $10K | |
| 82952 | 3,389 | 3,159 | $9K | |
| 86337 | 702 | 648 | $9K | |
| 86361 | 531 | 504 | $9K | |
| 80185 | 896 | 847 | $8K | |
| 86753 | 990 | 384 | $8K | |
| 86258 | 141 | 137 | $8K | |
| 81401 | 158 | 123 | $8K | |
| 86021 | 804 | 759 | $8K | |
| 84630 | 1,144 | 1,054 | $8K | |
| 86036 | 470 | 455 | $8K | |
| 83010 | 760 | 728 | $7K | |
| 82626 | 415 | 404 | $7K | |
| 86304 | 516 | 491 | $7K | |
| 84075 | 2,305 | 2,183 | $7K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 128 | 126 | $7K |
| 82390 | 998 | 956 | $7K | |
| 82378 | 565 | 532 | $7K | |
| 84132 | 2,226 | 2,055 | $7K | |
| 84155 | 2,919 | 2,788 | $7K | |
| 83521 | 160 | 146 | $7K | |
| 85004 | 1,420 | 1,335 | $6K | |
| 99199 | Unlisted special service, procedure or report | 3,049 | 2,137 | $6K |
| 86870 | 493 | 461 | $6K | |
| 84432 | 609 | 584 | $6K | |
| 83993 | 473 | 460 | $6K | |
| 85660 | 1,983 | 1,730 | $6K | |
| 81511 | 122 | 115 | $5K | |
| 82232 | 538 | 496 | $5K | |
| 87800 | 567 | 476 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 99 | 98 | $5K |
| 86702 | 795 | 745 | $5K | |
| 80342 | 444 | 379 | $5K | |
| 86596 | 118 | 113 | $4K | |
| 86812 | 263 | 256 | $4K | |
| 86382 | 205 | 195 | $4K | |
| 85613 | 646 | 624 | $4K | |
| 86060 | 807 | 740 | $4K | |
| 82157 | 239 | 231 | $4K | |
| 86631 | 245 | 224 | $4K | |
| 82642 | 183 | 178 | $4K | |
| 81015 | 1,985 | 1,865 | $4K | |
| 86308 | 1,110 | 1,065 | $4K | |
| 86682 | 839 | 422 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 185 | 175 | $4K |
| 85048 | 1,973 | 1,858 | $3K | |
| 81332 | 184 | 180 | $3K | |
| 88342 | 117 | 93 | $3K | |
| 84484 | 536 | 496 | $3K | |
| 84482 | 264 | 257 | $3K | |
| 84252 | 261 | 248 | $3K | |
| 80051 | 757 | 712 | $3K | |
| 86701 | 769 | 719 | $3K | |
| 87106 | 478 | 438 | $3K | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | 156 | 148 | $3K |
| 84590 | 434 | 406 | $3K | |
| 87350 | 396 | 383 | $3K | |
| 87581 | 92 | 91 | $3K | |
| 87486 | 92 | 91 | $3K | |
| 84295 | 972 | 937 | $3K | |
| 84446 | 340 | 314 | $3K | |
| 80299 | 227 | 150 | $3K | |
| 86360 | 84 | 78 | $3K | |
| 87634 | 58 | 56 | $3K | |
| 86632 | 254 | 237 | $3K | |
| 80055 | 82 | 81 | $3K | |
| 82088 | 101 | 93 | $2K | |
| 86692 | 200 | 194 | $2K | |
| 82435 | 815 | 789 | $2K | |
| 87493 | 110 | 108 | $2K | |
| 82747 | 187 | 183 | $2K | |
| 82365 | 239 | 231 | $2K | |
| 80156 | 183 | 175 | $2K | |
| 82166 | 126 | 123 | $2K | |
| 82374 | 616 | 595 | $2K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 54 | 51 | $2K |
| 86644 | 182 | 173 | $2K | |
| 83625 | 241 | 215 | $2K | |
| 87185 | 594 | 564 | $2K | |
| 86707 | 240 | 229 | $2K | |
| 81241 | 75 | 71 | $2K | |
| 82552 | 173 | 157 | $1K | |
| 84244 | 99 | 95 | $1K | |
| 80171 | 127 | 125 | $1K | |
| 86645 | 114 | 112 | $1K | |
| 87535 | 84 | 78 | $1K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 14 | 12 | $1K |
| 82985 | 144 | 139 | $1K | |
| 87101 | 209 | 200 | $1K | |
| 99499 | 24 | 24 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 154 | 149 | $1K |
| 82180 | 181 | 162 | $1K | |
| 82164 | 109 | 107 | $979.00 | |
| 82104 | 108 | 103 | $977.04 | |
| 83876 | 30 | 30 | $971.60 | |
| 84202 | 83 | 82 | $757.58 | |
| 82668 | 53 | 53 | $728.00 | |
| 86162 | 54 | 50 | $698.32 | |
| 85049 | 250 | 239 | $649.75 | |
| 80184 | 64 | 64 | $617.80 | |
| 87140 | 133 | 120 | $613.30 | |
| 85240 | 57 | 56 | $609.66 | |
| 85246 | 43 | 42 | $594.67 | |
| 84080 | 73 | 65 | $558.84 | |
| 82525 | 62 | 60 | $548.95 | |
| 87102 | 95 | 92 | $540.47 | |
| 80197 | 60 | 41 | $514.50 | |
| 84134 | 47 | 38 | $497.75 | |
| 89055 | 153 | 151 | $471.40 | |
| 84597 | 55 | 54 | $460.14 | |
| 80175 | 55 | 52 | $448.96 | |
| 87206 | 112 | 89 | $426.60 | |
| 83835 | 40 | 37 | $402.23 | |
| 82107 | 14 | 13 | $390.88 | |
| 86886 | 99 | 85 | $376.23 | |
| 86671 | 50 | 24 | $375.36 | |
| 87468 | 67 | 63 | $368.00 | |
| 87469 | 67 | 63 | $368.00 | |
| 86335 | 13 | 13 | $332.22 | |
| 87220 | 82 | 78 | $286.62 | |
| 87254 | 15 | 14 | $284.77 | |
| 85303 | 32 | 30 | $283.86 | |
| 85306 | 27 | 25 | $283.54 | |
| 85230 | 28 | 28 | $282.02 | |
| 87484 | 64 | 61 | $276.76 | |
| 87150 | 13 | 13 | $271.03 | |
| 83527 | 29 | 29 | $269.47 | |
| 85245 | 18 | 17 | $240.16 | |
| 86615 | 16 | 14 | $231.99 | |
| 82530 | 16 | 13 | $209.67 | |
| 81240 | 14 | 13 | $203.48 | |
| 99001 | 1,846 | 1,233 | $173.74 | |
| 86790 | 24 | 12 | $152.29 | |
| 87107 | 25 | 25 | $146.13 | |
| 85598 | 12 | 12 | $125.93 | |
| 82085 | 13 | 13 | $125.59 | |
| 86340 | 12 | 12 | $125.39 | |
| 80375 | 21 | 20 | $110.40 | |
| 80162 | 13 | 12 | $104.22 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 13 | 12 | $86.94 |
| 85651 | 37 | 37 | $77.56 | |
| 84591 | 27 | 26 | $60.84 | |
| 87467 | 12 | 12 | $26.95 | |
| 3049F | 4,915 | 4,773 | $0.00 | |
| 3048F | 7,629 | 7,421 | $0.00 | |
| 3044F | 8,741 | 8,490 | $0.00 | |
| 3052F | 468 | 461 | $0.00 | |
| 3051F | 890 | 868 | $0.00 | |
| 3046F | 875 | 846 | $0.00 | |
| 3050F | 3,791 | 3,694 | $0.00 |